ADVERTISEMENT
Posted: Aug 8, 2025

Suicide prevention: The pharmacist’s role in saving lives

CPE

I had not seen him in my office for almost a year. Generally, when I have a patient who I have not seen for some time, I'm able to locate some notes through the chart that prompts me for the reason they have outreached.

Zachary Hill, PharmD, BCPP, MA

Read more
Posted: Aug 6, 2025

Opportunities to implement the American College of Physicians migraine treatment guidelines

CPE

Community pharmacists suggest a “migraine product” more than 77,000 times per day, ranking as one of their most frequent OTC product recommendations. Among individuals who experience migraines, 97% currently consume either a nonprescription or prescription medication, or both.

Richard Wenzel, PharmD, CPPS; Bradley Torphy, MD; and Matthew Wolter, PharmD candidate

Read more
Posted: Jul 7, 2025

New therapeutic agents marketed in 2024: Part 2

CPE

FDA approved 50 new (“novel”) drugs in 2024 that had not been approved or marketed in the United States.

Mark S. Johnson, PharmD, MACE, BCPS

Read more
Posted: Jun 7, 2025

Shining a light on drug-induced photosensitivity

CPE

Drug-induced photosensitivity reactions are cutaneous adverse drug reactions (ADRs) which occur after exposure to both a sensitizing medication and ultraviolet radiation (UVR).

Michelle Dano, PharmD

Read more
Posted: May 7, 2025

Recognizing benzodiazepine-induced neurological dysfunction

CPE

An estimated 30.6 million adults in the United States will use benzodiazepines within the past year. Benzodiazepines are prescribed for a wide range of conditions, including anxiety, insomnia, muscle spasms, anesthesia, catatonia, status epilepticus, and withdrawal from alcohol or benzodiazepines.

Thao Anh Mai, PharmD; Kami Johnston, PharmD; Jeffrey D. Gold, PharmD, BCPP

Read more
1345678910Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT